# M Ventures

M Ventures is a Venture Capital based in Los Angeles, Netherlands.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Los Angeles, Netherlands
- **Region:** North America
- **Address:** Eduard van Beinumstraat 26, 1077 CZ Amsterdam, Netherlands
- **Founded:** 2009
- **Assets under management:** Undisclosed
- **Website:** www.m-ventures.com
- **LinkedIn:** https://www.linkedin.com/company/merck-ventures

## Regulatory record

- **CRD number:** 296621
- **SEC file number:** 802-114541
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/296621

## About

M Ventures is the strategic, corporate venture capital fund of Merck KGaA, Darmstadt, Germany, investing in Biotechnology and Technology. It covers Healthcare drug development, Life Science tools, Electronics and Frontier Technology & Sustainability. It invests with dual strategic and financial foci into visionary companies and takes an active role in portfolio companies, teaming up with entrepreneurs and co-investors.

## Sectors

- Healthcare Services
- Enterprise Software
- AI/ML
- SpaceTech
- Digital Health
- AgriTech & FoodTech
- Industrial Tech
- Cybersecurity
- Mobility & Transportation

## Offices

- Helsinki, Finland
- Berlin, Germany
- Los Angeles, United States
- Stockholm, Sweden

## People

- Hakan Goker — Managing Director
- Javier Rodriguez — Head Technology Investments
- Caroline Soulard — Chief Financial Officer
- Ebru Uzun — Head of Business Operations

## Questions

### Who runs investment decisions at M Ventures?

Managing Director Hakan Goker leads the investment team, with Javier Rodriguez heading Technology Investments. Decisions are made by an executive director group that includes Bauke Anninga, Christian Patze, Christian Uhrich, and Daniel Franke, drawing on expertise across biotechnology, electronics, and frontier technology.

### How does M Ventures source proprietary deal flow?

The firm originates deal flow through its embedded relationship with Merck KGaA, identifying spin-offs from internal research (such as Calypso Biotech) and co-developing companies that align with the parent's R&D priorities. It also maintains a network of co-investors and academic institutions across its European, Israeli, and US offices.

### Is M Ventures a typical venture capital firm or something else?

M Ventures operates as a strategic corporate venture capital fund. It pursues dual financial and strategic returns — meaning every investment must offer a credible path to commercial return while also complementing Merck KGaA's therapeutic, tool, or technology roadmaps.

### Does M Ventures invest only directly or also via co-investment?

The firm participates in direct equity financings and regularly co-invests alongside other venture and growth equity funds. Portfolio company statements indicate M Ventures was instrumental in building syndicates for rounds such as the Series A for LabGenius and later-stage financings for STORM Therapeutics.

### What stages does M Ventures typically target?

M Ventures invests across early-stage (seed and startup) and growth stages. It has backed companies from initial conception through to IPO (Translate Bio, Progyny, Galecto Biotech) and M&A exits (Ambrx, Synaffix BV, Calypso Biotech), often holding positions through multiple funding rounds.

### How is M Ventures related to Merck KGaA?

M Ventures is the wholly owned corporate venture arm of Merck KGaA, Darmstadt, Germany. It receives its capital allocation from the parent and operates with access to Merck's research scientists, labs, and commercial infrastructure, though it makes independent investment decisions.

### Does M Ventures maintain a separate capital structure or raise external funds?

The firm operates on a €600 million allocation from its corporate parent, Merck KGaA. It has not raised external limited partner capital. All portfolio activity is funded through this dedicated corporate venture budget, which supports both new investments and follow-on rounds.

## Related profiles

- [M-Venture Investment](https://altss.com/profile/m-venture-investment)
- [MV Holding](https://altss.com/profile/mv-holding)

---

Last updated: 2026-08-11T15:07:19.634Z

Canonical page: https://altss.com/profile/m-ventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology